Follicular thyroid carcinoma (FTC) is a relatively rare form of differentiated thyroid carcinoma, but it is important to recognise that FTC may be very aggressive, may not respond to radioiodine treatment and may cause life-threatening complications [1, 2] .
The use of 18 F-fluorodeoxyglucose positron emission tomography/computed tomography ( 18 F-FDG PET/CT) has rapidly grown in the latest years in patients with differentiated thyroid carcinoma (DTC) with a negative radio-iodine scan despite clearly elevated levels of thyroglobulin [3] . The biological pattern of DTC, which loses its thyroid-specific iodidetrapping properties and becomes FDG-avid, reflects enhanced aggressiveness and is related to a worse prognosis than FDGnegative tumours [4] . In addition, there is evidence that several factors associated with FDG positivity (tumour size, lymph node metastasis, and glucose transporter expression and differentiation) are related to a poor prognosis in patients with FTC [5] .
A 78-year-old woman with a history of FTC came under our observation to undergo an 18 F-FDG PET/CT scan for the first time for restaging purpose. Total thyroidectomy had been performed 19 years previously and radio-iodine treatment reached a total activity level of 1.8 Ci (66.6 GBq) over 10 years. The aggressive treatment did not prevent the development of a widespread metastatic disease involving lymph nodes and bones. The most painful bone metastases were treated with external beam radiation therapy, with effective relief of the symptoms. A suppressive therapy with L-thyroxine was started. Thyroglobulin levels were checked yearly, and were relatively high but under control (maximum value, 32.3 ng/ml). However, the thyroglobulin levels suddenly rose up to 117.5 ng/ml 6 months previously. A 131 I whole-body scan was requested but the result was negative (Fig. 1) . Therefore the patient was referred to our department to undergo an (Fig. 2a) . Moreover, there was evidence of another pathological uptake (SUVmax 7.3) in the left adrenal gland (Fig. 2b-d) . The adrenal lesion was surgically removed and pathological examination revealed metastasis from the FTC (Fig. 3) .
The patient was then referred to the clinical oncologist to evaluate possible further therapies.
The adrenal gland is a very uncommon site of metastatic spread from thyroid carcinoma. Only a few cases have been reported in the literature, describing adrenal metastases in patients affected by papillary thyroid carcinoma [6] [7] [8] or anaplastic thyroid carcinoma [9] .
Although a case of iodine-avid adrenal lesion has been described previously [10] , to our knowledge, this is the first case report of an adrenal gland metastasis imaged by Informed consent was obtained from all patients for being included in the study.
